Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 - January 2022.
Journal Information
Full Title: Vaccine
Abbreviation: Vaccine
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Allergy and Immunology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"appendix a supplementary data the following are the supplementary data to this article: supplementary data 1 data availability the data that has been used is confidential."
"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
"Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The study was performed as part of routine work at the Norwegian Institute of Public Health."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025